Streptococcal A vaccine - SIGA

Drug Profile

Streptococcal A vaccine - SIGA

Alternative Names: StrepImmune

Latest Information Update: 23 Sep 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator SIGA Technologies
  • Class Streptococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Streptococcal infections

Most Recent Events

  • 16 Aug 2002 This vaccine is still in active development
  • 29 Dec 2000 Phase-I clinical trials in Streptococcal infections in USA (unspecified route)
  • 15 Oct 1999 SIGA has been awarded a SBIR grant for development of the vaccine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top